280 related articles for article (PubMed ID: 15113380)
1. Implementation of a strategy to prevent TRALI in a regional blood centre.
Insunza A; Romon I; Gonzalez-Ponte ML; Hoyos A; Pastor JM; Iriondo A; Hermosa V
Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
[TBL] [Abstract][Full Text] [Related]
2. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
Keller-Stanislawski B; Reil A; Günay S; Funk MB
Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
[TBL] [Abstract][Full Text] [Related]
3. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
4. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
[TBL] [Abstract][Full Text] [Related]
5. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
[TBL] [Abstract][Full Text] [Related]
6. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
Sachs UJ; Kauschat D; Bein G
Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
[TBL] [Abstract][Full Text] [Related]
8. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation.
Nicolle AL; Chapman CE; Carter V; Wallis JP
Transfus Med; 2004 Jun; 14(3):225-30. PubMed ID: 15180814
[TBL] [Abstract][Full Text] [Related]
9. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-related acute lung injury: current concepts for the clinician.
Triulzi DJ
Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
Curtis BR; McFarland JG
Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
[TBL] [Abstract][Full Text] [Related]
12. Leucocyte antibodies in blood donors and a look back on recipients of their blood components.
Maślanka K; Michur H; Zupańska B; Uhrynowska M; Nowak J
Vox Sang; 2007 Apr; 92(3):247-9. PubMed ID: 17348874
[TBL] [Abstract][Full Text] [Related]
13. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
Reil A; Keller-Stanislawski B; Günay S; Bux J
Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
[TBL] [Abstract][Full Text] [Related]
14. Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI).
Mair DC; Hirschler N; Eastlund T
Crit Care Med; 2006 May; 34(5 Suppl):S137-43. PubMed ID: 16617258
[TBL] [Abstract][Full Text] [Related]
15. Transfusion-related acute lung injury reports in the Netherlands: an observational study.
van Stein D; Beckers EA; Sintnicolaas K; Porcelijn L; Danovic F; Wollersheim JA; Brand A; van Rhenen DJ
Transfusion; 2010 Jan; 50(1):213-20. PubMed ID: 19694998
[TBL] [Abstract][Full Text] [Related]
16. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
Kleinman S; Grossman B; Kopko P
Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion.
Bux J
Vox Sang; 2005 Jul; 89(1):1-10. PubMed ID: 15938734
[TBL] [Abstract][Full Text] [Related]
18. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
Eder AF; Dy BA; O'Neill EM
Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
[TBL] [Abstract][Full Text] [Related]
19. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report.
Lydaki E; Bolonaki E; Nikoloudi E; Chalkiadakis E; Iniotaki-Theodoraki A
Transfus Apher Sci; 2005 Oct; 33(2):107-11. PubMed ID: 16115801
[TBL] [Abstract][Full Text] [Related]
20. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]